The c-maf gene expression profile was investigated in normal and osteoarthritic articular cartilage using in situ hybridization, qualitative reverse transcription-polymerase chain reaction (RT-PCR) and quantitative real-time RT-PCR. Osteoarthritic samples were obtained from 10 patients undergoing total knee replacement for severe osteoarthritis of the knee joints, and control samples from 10 trauma patients undergoing amputation. Expression of c-maf was significantly upregulated in osteoarthritic cartilage compared with normal cartilage. Using in situ hybridization, distribution of a specific c-maf mRNA signal was found in the top zone and a decreased signal was found in the lower middle zone and the deep zone in osteoarthritic cartilage. A prominent cmaf mRNA signal was seen particularly in proliferating 'chondrocyte clusters'. In contrast, in normal cartilage almost no cmaf-positive cells were found. These findings suggest that c-maf may be important in chondrocyte hypertrophy and terminal differentiation, and may be involved in the pathogenesis of osteoarthritis.
Introduction
Osteoarthritis (OA) involves the entire synovial joint, including the cartilage, the synovium and the underlying bone. 1 In the past it was generally regarded as a degenerative disease caused mainly by wear and tear, however there is now increasing evidence indicating that abnormal articular chondrocyte differentiation contributes to the progression of OA. 2 -4 The protein c-maf is a member of the basic leucine zipper (bZIP) superfamily; 5 the c-maf gene is the cellular homologue of the avian oncogene v-maf. 6 Although chromosomal translocations of c-maf have been shown in multiple myeloma , 7 several reports indicate that the maf proteins participate in the process of development and differentiation, for example mafB in the hindbrain, 8 mafK in erythroid cells, 9 c-maf in helper T-cells 10 and Lcmaf in the lens. 11 Recent studies have shown that c-maf is highly expressed in hypertrophic chondrocytes and is required for normal chondrocyte differentiation during endochondral bone development; absence of c-maf causes a decrease in the number of mature hypertrophic chondrocytes. 12 Therefore, c-maf may be involved in the process of chondrocyte hypertrophy and terminal differentiation.
The present study was set up to explore the role of c-maf in articular chondrocytes by T Li, J Xiao, Z Wu et al.
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investigating the expression profile of the cmaf gene in chondrocytes from patients with and without OA using in situ hybridization, qualitative reverse transcription-polymerase chain reaction (RT-PCR) and quantitative real-time RT-PCR.
Patients and methods

CARTILAGE SAMPLES
Cartilage samples were obtained from patients undergoing total knee replacement for severe OA of the knee joints; control samples were obtained from trauma patients without OA who were undergoing amputation. All tissue samples were graded according to a modified Mankin scale, 13 with a score of < 3 being defined as normal and a score > 5 representing OA.
The study protocol was approved by the Peking Union Medical College Ethics Review Board.
REVERSE TRANSCRIPTION
Total mRNA was isolated directly from fresh cartilage samples using the RNeasy Fibrous Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. Reverse transcription was performed using ReverTra Ace-α ® (Toyobo, Osaka, Japan) according to the manufacturer's protocol. The reaction mixture consisted of 4 µl of 5× reverse transcription buffer, 2 µl deoxyribonucleotide triphosphate mixture, 1 µl RNase inhibitor, 1 µl oligo deoxythymidylic (dT)20, 1 µl ReverTra Ace-α ® and 500 ng total RNA from each sample. It was incubated in a GeneAmp ® PCR System 9700 (Applied Biosystems, Foster City, CA, USA) for 20 min at 42°C, 5 min at 99°C and then held at 4°C. The reaction mixture was then diluted to 200 µl with RNase-free water and stored at -20°C until qualitative RT-PCR or quantitative real-time RT-PCR were undertaken.
Qualitative RT-PCR
The qualitative RT-PCR reaction was carried out using the following cycling conditions: denaturing at 95°C for 5 min, followed by 35 cycles at 95°C for 30 s, annealing at 56°C for 30 s and extension at 72°C for 1 min. The specific primers were: c-maf, 5′-CCGC ATCATCAGCCAGTG-3′ (forward) and 5′-GCGCGTAGCCATCGAAG-3′ (reverse); glyceraldehyde-3-phosphate dehydrogenase (GAPDH) reference gene, 5′-TGATGACA TCAAGAAGGTGGTGAAG-3′ (forward) and 5′ -TCCTTGGAGGCCATGTGGGCCAT-3′ (reverse). The PCR products were separated on 2% agarose gel and visualized by ethidium bromide staining.
Quantitative real time RT-PCR Quantitative
real-time RT-PCR was performed with the ABI 7500 Real-Time PCR System (Applied Biosystems) using 20 µl of mixture containing cDNA, specific primers for each gene and the SYBR ® Green PCR MasterMix Reagent (Applied Biosystems). Samples were denaturated for 15 min at 95°C and then amplified for 45 cycles as follows: denaturating at 95°C for 15 s, annealing at 60°C for 30 s, and extension at 72°C for 30 s and 72°C for 1 min. The specific primers for each gene were: c-maf, 5′-AGCGGCTTCCGAGAAAAC-3′ (forward) and 5′-ACTTGCGAGTGGGCTCAG-3′ (reverse); GAPDH reference gene, 5′-CTCTGCTCCTC CTGTTCGAC-3′ (forward) and 5′-ACGACC AAATCCGTTGACTC-3′ (reverse). The generation of specific PCR products was confirmed by melting curve analysis. For each RT-PCR run, parallel samples were run.
IN SITU HYBRIDIZATION
Cartilage sections were deparaffinized and rehydrated through a graded series of ethanol, and endogenous peroxidase was blocked by incubation with 3% hydrogen peroxide for 10 T Li, J Xiao, Z Wu et al.
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min. After being washed with distilled water and treated with 0.1% diethylpyrocarbonate three times for 5 min each, the slides were digested with pepsin diluted with 3% citric acid at 37°C for 15 -20 min.
A specific probe for c-maf was constructed (5′-TTGCTCATTGCCAGTTCTGATGCCATTC TCCTGCC-3′) and labelled using digoxins. For the in situ hybridization, 20 ml prehybridization reagent was added to each slide at 37°C for 2 h, then 20 ml of probe was hybridized to each slide at 42°C for 16 -20 h. After hybridization, each slide was washed twice with 2× standard saline citrate (SSC) at 37°C for 20 min each, then twice with 0.2× SSC at 37°C for 10 min each. Blocking reagent was added to the slides and incubated for 30 min, and then mouse anti-digoxin antibody labelled with biotin was added at 37°C for 60 min. After washing with 0.5 M phosphate buffered saline (PBS), pH 7.4, three times for 2 min each, the slides were incubated with (strept)avidin-biotin complex for 20 min at 37°C, then washed with 0.5 M PBS, pH 7.4, four times for 5 min each. Finally, the chromogen, diaminobenzidine, was added to visualize the peroxidase reaction products and the slides were counterstained for nuclei with haematoxylin. Positive c-maf mRNA expression was indicated by a brownyellow colour located in the cytoplasm and/or the nucleus. A negative control was prepared in a similar manner but with the c-maf probe substituted by 2× SSC.
STATISTICAL ANALYSIS
Results were reported as the mean ± SD. Differences between the OA and control groups were determined using t-tests. A Pvalue < 0.05 was considered to be statistically significant.
Results
Cartilage samples were obtained from 10 patients with OA (mean age 60 years, range 53 -79 years, Mankin score 7 -10 points) and 10 controls without OA (mean age 34 years, range 21 -53 years, Mankin score 0 -2 points).
EXPRESSION OF C-MAF IN CARTILAGE
Expression of c-maf mRNA was detected by RT-PCR in both OA and normal cartilage (Fig. 1) . Quantitative RT-PCR showed that cmaf mRNA expression was significantly higher (P = 0.001) in the OA samples than in the control samples (Fig. 2) .
LOCALIZATION OF C-MAF MRNA
On in situ hybridization, in OA cartilage samples the superficial zone was found to be eroded and, as a result, chondrocytes from the middle zone were localized nearer to the articular surface and a specific c-maf mRNA signal tended to be limited to the top zone (Fig. 3A) . In the remaining cartilage layers (lower middle zone and deep zone), staining intensity was decreased in all the OA cartilage samples (Fig. 3B ). In particular, proliferating chondrocytes arranged in clusters demonstrated a prominent c-maf mRNA signal (Fig. 3C ). The control samples (normal cartilage) had almost no positive cells in the superficial zone ( Fig. 3D ), middle zone ( Fig. 3E ) and deep zone (Fig. 3F ). 
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collagen type X, 15 annexins II, V and VI, alkaline phosphatase and matrix metalloproteinase-13 (MMP-13). 16 Phenotype alteration is a potential reason for the anabolic failure of chondrocytes in OA cartilage. Recent studies have shown that cmaf is highly expressed in hypertrophic chondrocytes and is required for normal chondrocyte differentiation during endochondral bone development; absence of c-maf causes a decrease in the number of mature hypertrophic chondrocytes. 12 Thus, c-maf facilitates both the initiation of terminal differentiation and the completion of chondrocyte differentiation. In the present study, expression of the c-maf gene was compared in normal and OA chondrocytes. Quantitative real-time RT-PCR showed an increase in c-maf expression in OA cartilage. Up-regulation of c-maf may contribute to phenotype change of chondrocytes.
In OA, the proliferation of chondrocytes leads to the formation of so-called 'chondrocyte clusters'. Chondrogenic cells in these clusters have a very high metabolic activity and not only show increased synthesis of physiological matrix components, such as collagen type II and type VI, 17, 18 but also begin to express bonerelated proteins, such as osteocalcin, alkaline phosphatase and collagen type X, indicating chondrocyte hypertrophy. 2 In the present study, the 'chondrocyte clusters' showed a prominent c-maf mRNA signal, demonstrating that OA chondrocytes undergo hypertrophy and terminal differentiation.
The observed increase in c-maf expression suggests that the protein c-maf may have a role in the pathogenesis of OA. Several reports have indicated that various genes related to the progression of OA may be potential targets for c-maf. MMP-13 has specific activity for collagen type II, which is induced in terminally differentiated chondrocytes and has been shown to be highly up-regulated in OA cartilage. 19 Studies on c-maf null mice have suggested that the transcription factor, c-maf, has a regulatory role for MMP-13, and MMP-13 could be a direct target of c-maf. 12 The overexpression of c-maf could, therefore, upregulate expression of MMP-13, which may contribute to both collagen and proteoglycan degradation in cartilage.
The transcription factor SOX9 has a crucial role in the commitment and chondrogenic differentiation of mesenchymal cells in developing skeletal tissue. 20 It may control early chondrogenic cell fate and differentiation upstream. The long-form of c-maf (LC-maf) is the first transcription factor that has been shown to interact with SOX9, that is co-expressed with SOX9 during the early stage of chondrogenesis and that cooperates with SOX9 in activating a downstream target gene of SOX9, such as the endogenous Col2a1 gene. 21 It may be, therefore, that cmaf and SOX9 are involved in the formation of 'chondrocyte clusters'.
In addition, c-maf may be involved in chondrocyte apoptosis. Apoptosis is enhanced in OA, particularly in the superficial and middle zones of articular cartilage. Researchers have suggested that apoptosis of articular chondrocytes may play a very important role in the loss of cellularity of chondrocytes. 22 It has been shown that c-maf can interact with the transcription factor c-myb to down-regulate BCL-2 expression, 23 and over-expression of c-maf induces p53-dependent cell death in primary cell lines. 24 In OA, over-expression of c-maf could induce chondrocyte apoptosis, which may accelerate progression of the disease.
In conclusion, the present study
